echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Annual report reveals "taking medicine at tuyere"? Investment opportunities of treasure island pharmaceutical industry

    Annual report reveals "taking medicine at tuyere"? Investment opportunities of treasure island pharmaceutical industry

    • Last Update: 2018-05-07
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    [China Pharmaceutical network enterprise news] in the past two years, due to the influence of the adjustment of medical reform policies and other factors, the pharmaceutical industry has experienced the pain of reform Although from the perspective of performance, it is also recovering slowly, but the overall trend of pharmaceutical index is weak, and the concussion has become the main theme of the past two years However, in 2018, with the continuous recovery of corporate performance, the general improvement of annual report and first quarter report, the improvement of market risk aversion under the expectation of trade friction and other factors, the pharmaceutical industry has gradually stood in the wind, with obvious signs of plate recovery According to wind data, in the secondary market, the performance of pharmaceutical stocks was very strong in March, with the overall monthly increase of the industry as high as 11.26%, ranking in the 28 sub industries of Shenwan The improvement of the stock market is naturally inseparable from the support of fundamental performance Wind data shows that as of April 21, 185 listed companies in the pharmaceutical and biological industry have released their 2017 annual report Among them, there are 147 companies with a positive year-on-year increase in net profit attributable to shareholders of listed companies, accounting for 79.46% of the total number of issuing companies Among them, the performance of treasure island pharmaceutical in 2017 is remarkable According to the annual report of the company, in 2017, the operating revenue of treasure island pharmaceutical reached 3.137 billion yuan, a year-on-year increase of 31.17%; the net profit attributable to shareholders of the listed company was 521 million yuan, a year-on-year increase of 2.22%; the net profit attributable to shareholders of the listed company after deducting non recurring profit and loss was 469 million yuan, a year-on-year increase of 31.18% In 2017, treasure island pharmaceutical industry actively responded to the call of national supply side reform, adhered to the development concept of cooperation, platform and sharing, accelerated the innovation of system and mechanism by adjusting product structure, optimizing production capacity layout, and linking the three strategic paths at home and abroad, focusing on cultivating and improving innovation oriented product capabilities, transformation based marketing capabilities, and mechanism based marketing capabilities Driven by the ability of talents and management and control, the company has established a market-oriented investment and operation management system with profit as the core and assets less than benefits, and built itself into a large pharmaceutical enterprise with international layout, rich product reserves, marketing ability, traditional Chinese medicine, chemical medicine and biological medicine In terms of R & D and innovation, in 2017, treasure island pharmaceutical industry actively promoted the introduction and transformation of new varieties, added 4 chemical medicine projects, and ibotinib capsule obtained the approval of clinical trials of drugs In the second development of the old varieties, breakthroughs have been made in such varieties as Xuesaitong for injection and Shuxuening injection At the big health industry forum of 2018 International Summit on innovative traditional Chinese medicine and Botanical Medicine held in Tengchong on March 24, 2018, treasure island pharmaceutical industry won the title of Chinese medicine enterprise with scientific and technological innovation ability in 2016, and again won the honor of 2017 At the same time, the compound qinlan oral liquid was awarded the title of 2017 national traditional Chinese medicine ingenuity product In terms of marketing, in 2017, treasure island Pharmaceutical Co., Ltd formulated a business strategy of drug marketing to protect the base, promote growth and promote transformation That is, to stabilize the existing basic sales volume through refined investment promotion and channel circulation mode; to take brand, academic and customer relationship management as the three strategic fulcrum of marketing, and to promote the establishment of self operating mode to strengthen terminal control around product upgrading, marketing transformation and professional chemical technology promotion In the aspect of traditional Chinese medicine industry, treasure island pharmaceutical started the management of traditional Chinese medicine Take the subsidiary company as the main business body, carry out long-term variety management, conventional variety management and short-term variety management Starting from the operation of Bozhou traditional Chinese medicine commodity trading center and driven by industrial investment, we plan to build the trading system of traditional Chinese medicine market and lay out the national market of origin of traditional Chinese medicine under the Internet environment, mainly including spot trading, electronic trading, warehousing and logistics and other supporting projects We have not yet laid out and built the market of origin in China Meanwhile, in 2017, treasure island pharmaceutical industry paid close attention to product quality and talent team building While carrying out the construction of quality brand project, establishing and improving the risk management mode of market drug safety, the company insists on integrating human resources work into the first-hand project, organizing and revising the company's strategic plan for human resources development, focusing on promoting key projects such as the organization structure sorting, the establishment of core leadership team, the construction of talent echelon and the training of reserve cadres In 2018, with the implementation of a series of policies such as provincial bidding and consistency evaluation in the new version of the medical insurance catalogue, the industry will have a significant impact, while in the development process of the pharmaceutical industry, biological innovative drug research and development will continue to be favored The industry believes that with the establishment of the state health insurance bureau and the introduction of deepening the VAT reform measures, it has a positive impact on some industries of traditional Chinese medicine In this context, treasure island said that in 2018, the company will consolidate the pharmaceutical real economy, promote the transformation of marketing mode, continue to promote the construction of smart + ecological traditional Chinese medicine trading system, and strengthen the management of enterprises and team building in accordance with the law At the same time, international R & D cooperation companies should pay more attention to all kinds of international cooperation strategies and approaches, promote R & D innovation in an international perspective, and enhance the global competitiveness of the company's international market Original title: annual report reveals "taking medicine at tuyere"? Investment opportunities of treasure island pharmaceutical industry
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.